Related Experiment Video
Updated: Jun 13, 2026

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens
Published on: October 25, 2019
cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis
Mark J Vignola1, David F Kashatus, Gregory A Taylor
1Departments of Molecular Genetics and Microbiology, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Infection with the obligate bacterial intracellular pathogen Chlamydia trachomatis leads to the sustained activation of the small GTPase RAS and many of its downstream signaling components. In particular, the mitogen-activated protein kinase ERK and the calcium-dependent phospholipase cPLA(2) are activated and are important for the onset of inflammatory responses. In this study we tested if activation of ERK and cPLA(2) occurred as a result of RAS signaling during infection and determined the relative contribution of these signaling components to chlamydial replication and survival. We provide genetic and pharmacological evidence that during infection RAS, ERK, and, to a lesser extent, cPLA(2) activation are uncoupled, suggesting that Chlamydia activates individual components of this signaling pathway in a non-canonical manner. In human cell lines, inhibition of ERK or cPLA(2) signaling did not adversely impact C. trachomatis replication. In contrast, in murine cells, inhibition of ERK and cPLA(2) played a significant protective role against C. trachomatis. We determined that cPLA(2)-deficient murine cells are permissive for C. trachomatis replication because of their impaired expression of beta interferon and the induction of immunity-related GTPases (IRG) important for the containment of intracellular pathogens. Furthermore, the MAPK p38 was primarily responsible for cPLA(2) activation in Chlamydia-infected cells and IRG expression. Overall, these findings define a previously unrecognized role for cPLA(2) in the induction of cell autonomous cellular immunity to Chlamydia and highlight the many non-canonical signaling pathways engaged during infection.
Insights
Chlamydia trachomatis infection activates RAS signaling pathways non-canonically. While ERK and phospholipase cPLA(2) inhibition doesn't affect human cells, it protects murine cells by boosting immunity-related GTPases (IRGs).
Area of Science:
- Cellular microbiology
- Immunology
- Molecular signaling
Background:
- Chlamydia trachomatis is an obligate intracellular bacterial pathogen.
- Infection triggers sustained activation of RAS GTPase and downstream signaling, including ERK and cPLA(2), crucial for inflammation.
- The precise role of RAS-mediated signaling in chlamydial replication and host immunity remains unclear.
Purpose of the Study:
- To investigate if ERK and cPLA(2) activation during Chlamydia infection results from RAS signaling.
- To determine the contribution of ERK and cPLA(2) to chlamydial replication and survival.
- To elucidate the mechanisms underlying host cell defense against Chlamydia.
Main Methods:
- Genetic and pharmacological inhibition of RAS, ERK, and cPLA(2) signaling pathways.
- Comparative analysis of Chlamydia trachomatis replication and survival in human and murine cell lines.
- Assessment of beta interferon and immunity-related GTPases (IRG) expression in infected cells.
- Investigation of the role of MAPK p38 in cPLA(2) activation and IRG expression.
Main Results:
- RAS, ERK, and cPLA(2) activation during Chlamydia infection are uncoupled, indicating non-canonical signaling.
- Inhibition of ERK or cPLA(2) did not impede C. trachomatis replication in human cells.
- Inhibition of ERK and cPLA(2) significantly protected murine cells against C. trachomatis, linked to impaired beta interferon and IRG expression in cPLA(2)-deficient cells.
- MAPK p38 was identified as the primary activator of cPLA(2) and IRG expression in infected cells.
Conclusions:
- Chlamydia trachomatis engages in non-canonical signaling pathways, uncoupling RAS, ERK, and cPLA(2).
- Phospholipase cPLA(2) plays a critical role in inducing cell-autonomous immunity against Chlamydia in murine cells via beta interferon and IRG induction.
- MAPK p38 is central to activating cPLA(2) and IRG-mediated immunity, highlighting a novel defense mechanism against intracellular pathogens.
Related Concept Videos
Bacterial Phylum Chlamydiae
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Antiviral System of Bacteria and Archaea: CRISPR
Regulation of Bacterial Virulence
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

